Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy-Reference-Cited by-同舟云学术

Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy

Published:2022-09-02 Issue:9 Volume:61 Page:1116-1120
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Costa Svedman Fernanda¹²,Jalsenius Marie²,Grozman Vitali³⁴,Bergqvist Mattias⁵,Söderdahl Fabian⁶,Rotstein Samuel²,Ny Lars⁷^ORCID,Egyhazi Brage Suzanne¹,Helgadottir Hildur¹²^ORCID

Affiliation:

1. Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

2. Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

3. Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden

4. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

5. Biovica International AB, Uppsala Science Park, Uppsala, Sweden

6. Statisticon AB, Uppsala, Sweden

7. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

Funder

Swedish Cancer society

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2121615

Reference20 articles.

1. Thymidine kinase 1 through the ages: a comprehensive review

2. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

3. Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

4. Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Energy-Efficient Test and Predictive Model for Recurrence After Radiotherapy in Localized Intermediate and Advanced Cervical Cancer Were Created Using Thymidine Kinase 1 in Conjunction with Inflammatory Markers and Tumor Markers;International Journal of General Medicine;2023-12

2. Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy;Cancer Research Communications;2023-05-18